AR038380A1 - 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco - Google Patents

2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco

Info

Publication number
AR038380A1
AR038380A1 ARP030100289A ARP030100289A AR038380A1 AR 038380 A1 AR038380 A1 AR 038380A1 AR P030100289 A ARP030100289 A AR P030100289A AR P030100289 A ARP030100289 A AR P030100289A AR 038380 A1 AR038380 A1 AR 038380A1
Authority
AR
Argentina
Prior art keywords
imidazolidinas
dialcoxi
pharmaco
fen
imino
Prior art date
Application number
ARP030100289A
Other languages
English (en)
Spanish (es)
Inventor
Esser Franz Dr
Pouzet Pascale Dr
Naoki Ishiguro
Kitagawa Hisato Dr
Muramatsu Ikunobu Prof
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR038380A1 publication Critical patent/AR038380A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP030100289A 2002-01-31 2003-01-31 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco AR038380A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
AR038380A1 true AR038380A1 (es) 2005-01-12

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100289A AR038380A1 (es) 2002-01-31 2003-01-31 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco

Country Status (20)

Country Link
EP (2) EP1333028A1 (https=)
JP (1) JP2005516066A (https=)
KR (1) KR20040074134A (https=)
CN (1) CN1617857A (https=)
AR (1) AR038380A1 (https=)
BR (1) BR0215560A (https=)
CA (1) CA2474588A1 (https=)
EA (1) EA200400877A1 (https=)
EC (1) ECSP045210A (https=)
HR (1) HRP20040691A2 (https=)
HU (1) HUP0402654A2 (https=)
IL (1) IL162776A0 (https=)
MX (1) MXPA04007250A (https=)
NO (1) NO20043614L (https=)
PE (1) PE20030819A1 (https=)
PL (1) PL369826A1 (https=)
TW (1) TW200418462A (https=)
UY (1) UY27628A1 (https=)
WO (1) WO2003064398A1 (https=)
ZA (1) ZA200405173B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
AU2009246600A1 (en) 2008-05-13 2009-11-19 Allergan, Inc. Naphthylmethylimidizoles for the treatment of stress urinary incontinence
BRPI0912604A2 (pt) * 2008-05-13 2019-09-10 Allergan Inc quinolinilmetilimidazóis como agentes terapêuticos
ES2672777T3 (es) * 2008-06-09 2018-06-18 Allergan, Inc. Métodos de tratamiento de estados con mediación alfa-adrenérgica
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP4714422A1 (en) * 2024-09-20 2026-03-25 Società Italo Britannica L. Manetti - H. Roberts & C.p.A. Composition for absorbing skin perspiration and/or body moisture

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
WO2003064398A1 (en) 2003-08-07
ZA200405173B (en) 2005-06-21
ECSP045210A (es) 2004-09-28
NO20043614L (no) 2004-08-30
MXPA04007250A (es) 2004-10-29
CN1617857A (zh) 2005-05-18
PE20030819A1 (es) 2003-10-20
HUP0402654A2 (hu) 2005-03-29
BR0215560A (pt) 2004-12-21
IL162776A0 (en) 2005-11-20
EA200400877A1 (ru) 2005-02-24
UY27628A1 (es) 2003-08-29
TW200418462A (en) 2004-10-01
HRP20040691A2 (en) 2004-12-31
PL369826A1 (en) 2005-05-02
JP2005516066A (ja) 2005-06-02
EP1472231A1 (en) 2004-11-03
CA2474588A1 (en) 2003-08-07
EP1333028A1 (en) 2003-08-06
KR20040074134A (ko) 2004-08-21

Similar Documents

Publication Publication Date Title
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
NO20034291L (no) 2-aminopropanolderivater
EA200500017A1 (ru) Новые соединения
AR100291A2 (es) Composición catártica
EA200300803A1 (ru) Производные ксантина, их получение и их применение в качестве лекарственных средств
ATE292634T1 (de) Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion
BR0002515A (pt) Derivados de 4-arilpiperidina para o tratamento do prurido
AR061134A1 (es) Derivados de tioxantina
ATE427926T1 (de) Cycloalkylaminderivate
AR049274A1 (es) Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2
ATE386012T1 (de) Phenyloxyalkansäure-derivate als hppar aktivatore
AR038380A1 (es) 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
ES2117264T3 (es) Nuevo compuesto con actividad inhibitoria de la agregacion plaquetaria.
BR0002505A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
DE602004010529D1 (de) 2-amino-5-benzoylthiazol npy-antagonisten
DE60316436D1 (de) Amidderivate als inhibitoren der enzymatischen aktivität von renin
MA27143A1 (fr) Utilisation de derives de 2-amino-4- pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
DK1165485T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
GB0130868D0 (en) New compounds
DE60017374D1 (de) Antibakterielle mittel
EA200201023A1 (ru) Ингибитор натрий-водородного обмена типа 1(nhe-1)
AR042674A1 (es) [4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast

Legal Events

Date Code Title Description
FA Abandonment or withdrawal